| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.081 | 0.08 |